Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

Tat Ming Ng(Tan Tock Seng Hospital), David Chien Lye(Agency for Science, Technology and Research), Patrick N. A. Harris(The University of Queensland), Angela Chow(Tan Tock Seng Hospital), Partha Pratim De(Tan Tock Seng Hospital), Paul Anantharajah Tambyah(National University of Singapore), Wendy Xiao Ling Khong(Tan Tock Seng Hospital)
PLoS ONE
April 22, 2016
10.1371/journal.pone.0153696
Cited by 128

Related Papers

Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
|Nature Reviews Urology|2015|367
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature
|Journal of Thrombosis and Thrombolysis|2020|323
Health Risks of Flood Disasters
|Clinical Infectious Diseases|2018|253